ライフサイエンスコーパス: patients provided

1 -sided log-rank test with alpha = .15; 80 randomly assigned patients provided 89% power to detect a hazard ratio (HR) of

2 Seventy consecutive patients provided a vascular lesion, a blood sample, and 36 s

3 Pooled data extracted from 63,740 evaluable ICU patients provided an estimated prevalence of methicillin-resi

4 rmal pupillometry sensitivity in the majority of GUCY2D-LCA patients provided another objective efficacy outcome.

5 ) and 18 healthy controls (male 14; 44.5 [24-67] years); 21 patients provided another specimen after lactulose administra

6 A group of 151 patients provided at baseline their socioeconomic and medical

7 A subgroup of 835 patients provided blood samples from July 2010 through Septem

8 A total of 100 patients provided color descriptions of 11 distinct medicatio

9 479 (80%) patients provided data at 12 months.

10 2704 (70%) of 3851 patients provided data at 12 months.

11 A total of 779 patients provided data for the primary outcome measure at bas

12 Seven studies (2132 patients) provided data for the meta-analysis.

13 ians produced equivalent scores for all components of PASI; patients provided equivalent scores for most PASI components,

14 48 (96%) patients provided follow-up data.

15 Clinicians and patients provided full written consent to be interviewed and

16 ng CBT and pharmacotherapy for unipolar depression in 1,700 patients provided individual pre- and posttreatment scores on

17 All patients provided informed consent in this institutional revi

18 Materials and Methods Thirty recruited patients provided informed consent in this institutional revi

19 double-blinded, placebo-controlled clinical trial, and all patients provided informed consent.

20 All study patients provided informed consent.

21 tive study received institutional review board approval and patients provided informed consent.

22 as approved by the local ethics committee, and all 20 adult patients provided informed consent.

23 nal review board for this prospective single-arm study, and patients provided informed consent.

24 Of 26 eligible RCTs identified, 15 RCTs (1711 patients) provided moderate-quality evidence that SMT has a s

25 Consenting patients provided nasopharyngeal swab specimens for RSV testi

26 131 (92%) of 142 patients provided outcome data (59 in the depression care for

27 7012 vs 7283) were randomly assigned, of whom 16,211 (77%) patients provided primary outcome data (n=5171 vs 5468 vs 557

28 All patients provided signed consent, and the local research ethi

29 next-generation sequencing in inherited congenital cataract patients provided significant diagnostic information.

30 m that fMRI is both feasible and is tolerated well by these patients provided strict safety measures are adhered to.

31 strength measurement has proven reliable in critically ill patients provided that strict guidelines on adequacy and stan

32 At baseline, 331 patients provided their socioeconomic and medical data (comor

33 Of the 16 eligible studies, authors of 8 studies (n = 1120 patients) provided their data sets.

34 lectrical impedance analysis in 128 gastrointestinal cancer patients provided with or without FO-enriched nutrition durin

35 were approved by local institutional review boards, and all patients provided written consent.

36 ive MS multiple sclerosis ( SPMS secondary progressive MS ) patients provided written informed consent and underwent 3-T

37 All patients provided written informed consent before the study;

38 All patients provided written informed consent for study particip

39 with the principles of the Declaration of Helsinki, and all patients provided written informed consent prior to enrollmen

40 All patients provided written informed consent prior to undergoin

41 All patients provided written informed consent.

42 All patients provided written informed consent.

43 udy was approved by the institutional review board, and all patients provided written informed consent.

44 The local review board approved the protocol, and all patients provided written informed consent.

45 Institutional review board approval was obtained, and all patients provided written informed consent.

46 All patients provided written informed consent.

47 utional review board of all four participating centers, and patients provided written informed consent.

48 All patients provided written informed consent.

49 eview board-approved protocol and HIPAA compliance, and all patients provided written informed consent.

50 s study was approved by the local ethics committee, and all patients provided written informed consent.